Evidence map›Paper›PMID 25904795›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy.

Firyal Ramzan, Mike McPhail, Pengcheng Rao, Kaiguo Mo, Katherine Halievski, Ashlyn Swift-Gallant, Lucia Mendoza-Viveros, Hai-Ying M Cheng, D Ashley Monks

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  2. Review
  3. Article
  4. Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The first year.Acta neuropathologica · 2020
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Polyglutamine androgen receptor-mediated neuromuscular disease.Cellular and molecular life sciences : CMLS · 2016
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.Journal of molecular neuroscience : MN · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Firyal RamzanDepartment of Psychology.
Mike McPhailInstitute of Medical Sciences, University of Toronto, Mississauga, Ontario L5L 1C6, Canada.
Pengcheng RaoDepartment of Psychology.
Kaiguo MoDepartment of Psychology.
Katherine HalievskiDepartment of Psychology.
Ashlyn Swift-GallantDepartment of Psychology.
Lucia Mendoza-ViverosDepartment of Cell and Systems Biology, and.ORCID http://orcid.org/0000-0001-9707-859X
Hai-Ying M ChengDepartment of Cell and Systems Biology, and.
D Ashley MonksDepartment of Psychology, Department of Cell and Systems Biology, and Institute of Medical Sciences, University of Toronto, Mississauga, Ontario L5L 1C6, Canada ashley.monks@utoronto.ca.ORCID http://orcid.org/0000-0002-0972-4422
Institute of Psychology · RUUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research JNM-116637Canadian Institutes of Health Research MOP-126090Canadian Institutes of Health Research MOP-86549
6 · The paper itself

Abstract

Polyglutamine (polyQ) expansion of the androgen receptor (AR) causes Kennedy's disease/spinobulbar muscular atrophy (KD/SBMA) through poorly defined cellular mechanisms. Although KD/SBMA has been thought of as a motor neuron disease, recent evidence indicates a key role for skeletal muscle. To resolve which early aspects of the disease can be caused by neurogenic or myogenic mechanisms, we made use of the tet-On and Cre-loxP genetic systems to selectively and acutely express polyQ AR in either motor neurons (NeuroAR) or myocytes (MyoAR) of transgenic mice. After 4 weeks of transgene induction in adulthood, deficits in gross motor function were seen in NeuroAR mice, but not MyoAR mice. Conversely, reduced size of fast glycolytic fibers and alterations in expression of candidate genes were observed only in MyoAR mice. Both NeuroAR and MyoAR mice exhibited reduced oxidative capacity in skeletal muscles, as well as a shift in fast fibers from oxidative to glycolytic. Markers of oxidative stress were increased in the muscle of NeuroAR mice and were reduced in motor neurons of both NeuroAR and MyoAR mice. Despite secondary pathology in skeletal muscle and behavioral deficits, no pathological signs were observed in motor neurons of NeuroAR mice, possibly due to relatively low levels of polyQ AR expression. These results indicate that polyQ AR in motor neurons can produce secondary pathology in muscle. Results also support both neurogenic and myogenic contributions of polyQ AR to several acute aspects of pathology and provide further evidence for disordered cellular respiration in KD/SBMA skeletal muscle.

Indexed as

Disease Models, AnimalAnimalsGene ExpressionMaleMiceMice, TransgenicMotor NeuronsMotor SkillsMuscle CellsMuscle, SkeletalMuscular Disorders, AtrophicOxidative StressReceptors, AndrogenReceptors, Androgenandrogen receptorneuromuscularpolyglutamineSBMAskeletal muscletransgenic mice

Identifiers

PMID25904795
PMCPMC6605215
OpenAlexW2082741107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.